{
  "episodeId": "YRw1coVNxGc",
  "channelSlug": "@earnmoar",
  "title": "$ANGO AngioDynamics Q3 2025 Earnings Conference Call",
  "publishedAt": "2025-04-02T19:15:01.000Z",
  "rawLines": [
    {
      "lang": "en",
      "text": "good morning and welcome to the angio",
      "offset": 0.32,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "dynamics fiscal year 2025 third quarter",
      "offset": 2.08,
      "duration": 5.279
    },
    {
      "lang": "en",
      "text": "earnings call At this time all",
      "offset": 4.96,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "participants are in a listenon mode A",
      "offset": 7.359,
      "duration": 4.001
    },
    {
      "lang": "en",
      "text": "question and answer session will follow",
      "offset": 9.76,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "the formal presentation If anyone should",
      "offset": 11.36,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "require operator assistance during the",
      "offset": 13.92,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "conference please press star zero on",
      "offset": 15.599,
      "duration": 4.481
    },
    {
      "lang": "en",
      "text": "your telephone keypad As a reminder this",
      "offset": 17.52,
      "duration": 5.839
    },
    {
      "lang": "en",
      "text": "conference call is being recorded",
      "offset": 20.08,
      "duration": 5.68
    },
    {
      "lang": "en",
      "text": "The news release detailing angodnamics",
      "offset": 23.359,
      "duration": 5.441
    },
    {
      "lang": "en",
      "text": "fiscal 2025 third quarter results",
      "offset": 25.76,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "crossed the wire earlier this morning",
      "offset": 28.8,
      "duration": 3.96
    },
    {
      "lang": "en",
      "text": "and is available on the company's",
      "offset": 30.96,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "website This conference call is also",
      "offset": 32.76,
      "duration": 4.6
    },
    {
      "lang": "en",
      "text": "being broadcast live over the internet",
      "offset": 35.12,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "at the investor section of the company's",
      "offset": 37.36,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "website at",
      "offset": 39.36,
      "duration": 2.719
    },
    {
      "lang": "en",
      "text": "www.angodnamics.com A webcast replay of",
      "offset": 43,
      "duration": 4.6
    },
    {
      "lang": "en",
      "text": "the call will be available at the same",
      "offset": 45.36,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "site approximately 1 hour after the end",
      "offset": 47.6,
      "duration": 5.279
    },
    {
      "lang": "en",
      "text": "of today's call",
      "offset": 49.84,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "Before we begin I'd like to caution",
      "offset": 52.879,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "listeners that during the course of this",
      "offset": 55.28,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "conference call the company will make",
      "offset": 57.199,
      "duration": 3.2
    },
    {
      "lang": "en",
      "text": "projections or forward-looking",
      "offset": 59.12,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "statements regarding future events",
      "offset": 60.399,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "including statements about expected",
      "offset": 62.48,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "revenue adjusted earnings and gross",
      "offset": 64.32,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "margins for fiscal year 2025 as well as",
      "offset": 66.88,
      "duration": 6.239
    },
    {
      "lang": "en",
      "text": "trends that may continue",
      "offset": 70.08,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "Management encourages you to review the",
      "offset": 73.119,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "company's past and future filings with",
      "offset": 75.04,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "the SEC including without limitation the",
      "offset": 76.799,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "company's forms 10Q and 10K which",
      "offset": 79.92,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "identify specific factors that may cause",
      "offset": 82.799,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "the actual results or events to differ",
      "offset": 84.96,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "materially from those described in the",
      "offset": 87.439,
      "duration": 3.881
    },
    {
      "lang": "en",
      "text": "forward-looking",
      "offset": 89.52,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "statements The company will also discuss",
      "offset": 91.32,
      "duration": 5.159
    },
    {
      "lang": "en",
      "text": "certain non-GAAP and pro- fora financial",
      "offset": 93.759,
      "duration": 5.201
    },
    {
      "lang": "en",
      "text": "measures during this call Management",
      "offset": 96.479,
      "duration": 4.241
    },
    {
      "lang": "en",
      "text": "uses these measures to establish",
      "offset": 98.96,
      "duration": 3.839
    },
    {
      "lang": "en",
      "text": "operational goals and review operational",
      "offset": 100.72,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "performance and believes that these",
      "offset": 102.799,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "measures may assist investors in",
      "offset": 104.72,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "analyzing the underlying trends in the",
      "offset": 106.479,
      "duration": 5.201
    },
    {
      "lang": "en",
      "text": "company's business over time Investors",
      "offset": 108.72,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "should consider these non-GAAP and",
      "offset": 111.68,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "pro-former measures in addition to not",
      "offset": 113.439,
      "duration": 5.121
    },
    {
      "lang": "en",
      "text": "as a substitute for or as superior to",
      "offset": 115.92,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "financial reporting measures prepared in",
      "offset": 118.56,
      "duration": 5.199
    },
    {
      "lang": "en",
      "text": "accordance with GAP A slide package",
      "offset": 120.56,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "offering insight into the company's",
      "offset": 123.759,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "financial results is also available in",
      "offset": 125.52,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "the investor section of the company's",
      "offset": 128.08,
      "duration": 4.28
    },
    {
      "lang": "en",
      "text": "website under events and",
      "offset": 130.08,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "presentations This presentation should",
      "offset": 132.36,
      "duration": 4.44
    },
    {
      "lang": "en",
      "text": "be read in conjunction with a press",
      "offset": 134.56,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "release discussing the company's",
      "offset": 136.8,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "operating results and financial",
      "offset": 138.239,
      "duration": 3.761
    },
    {
      "lang": "en",
      "text": "performance during this morning's",
      "offset": 140.48,
      "duration": 2.6
    },
    {
      "lang": "en",
      "text": "conference",
      "offset": 142,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "call Now I'd like to turn the call over",
      "offset": 143.08,
      "duration": 5.4
    },
    {
      "lang": "en",
      "text": "to Jim Cleur and Geodynamics President",
      "offset": 145.76,
      "duration": 6.08
    },
    {
      "lang": "en",
      "text": "and Chief Executive Officer Mr Clemer",
      "offset": 148.48,
      "duration": 5.839
    },
    {
      "lang": "en",
      "text": "Thank you operator Good morning everyone",
      "offset": 151.84,
      "duration": 4.44
    },
    {
      "lang": "en",
      "text": "and thank you for joining us for",
      "offset": 154.319,
      "duration": 4.041
    },
    {
      "lang": "en",
      "text": "Angnamics fiscal",
      "offset": 156.28,
      "duration": 6.039
    },
    {
      "lang": "en",
      "text": "2025 third quarter earnings call Joining",
      "offset": 158.36,
      "duration": 7.28
    },
    {
      "lang": "en",
      "text": "me on today's call is Steve Trobridge",
      "offset": 162.319,
      "duration": 6.241
    },
    {
      "lang": "en",
      "text": "Angodnamics executive vice president and",
      "offset": 165.64,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "chief financial",
      "offset": 168.56,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "officer I will begin today's call by",
      "offset": 169.879,
      "duration": 5.241
    },
    {
      "lang": "en",
      "text": "providing an overview of our recent",
      "offset": 172.72,
      "duration": 4.879
    },
    {
      "lang": "en",
      "text": "performance Steve will then provide a",
      "offset": 175.12,
      "duration": 5.119
    },
    {
      "lang": "en",
      "text": "detailed analysis of our third quarter",
      "offset": 177.599,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "financial performance including our",
      "offset": 180.239,
      "duration": 4.801
    },
    {
      "lang": "en",
      "text": "increased guidance and I will conclude",
      "offset": 182.56,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "with our outlook for the balance of the",
      "offset": 185.04,
      "duration": 4.479
    },
    {
      "lang": "en",
      "text": "year before opening the line for",
      "offset": 187.2,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "questions",
      "offset": 189.519,
      "duration": 4.561
    },
    {
      "lang": "en",
      "text": "Unless otherwise noted all financial",
      "offset": 191.28,
      "duration": 4.879
    },
    {
      "lang": "en",
      "text": "results and growth rates mentioned",
      "offset": 194.08,
      "duration": 5.239
    },
    {
      "lang": "en",
      "text": "during today's call are on a proforma",
      "offset": 196.159,
      "duration": 6.521
    },
    {
      "lang": "en",
      "text": "basis which exclude the results of the",
      "offset": 199.319,
      "duration": 7.081
    },
    {
      "lang": "en",
      "text": "dialysis and bioentry businesses that we",
      "offset": 202.68,
      "duration": 6.639
    },
    {
      "lang": "en",
      "text": "devested in June",
      "offset": 206.4,
      "duration": 6.559
    },
    {
      "lang": "en",
      "text": "2023 the pick and midline products that",
      "offset": 209.319,
      "duration": 6.321
    },
    {
      "lang": "en",
      "text": "we devested in February",
      "offset": 212.959,
      "duration": 6.161
    },
    {
      "lang": "en",
      "text": "2024 and the radio frequency and citra",
      "offset": 215.64,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "support catheter products that we",
      "offset": 219.12,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "discontinued in February",
      "offset": 221.36,
      "duration": 6.72
    },
    {
      "lang": "en",
      "text": "2024 Our third quarter was very strong",
      "offset": 224.68,
      "duration": 5.559
    },
    {
      "lang": "en",
      "text": "as momentum we developed during the",
      "offset": 228.08,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "first half of the year continued Total",
      "offset": 230.239,
      "duration": 6.72
    },
    {
      "lang": "en",
      "text": "worldwide revenue was $72 million",
      "offset": 233.04,
      "duration": 7.72
    },
    {
      "lang": "en",
      "text": "representing growth of over 9%",
      "offset": 236.959,
      "duration": 7.36
    },
    {
      "lang": "en",
      "text": "year-over-year Our medtech segment had",
      "offset": 240.76,
      "duration": 7.119
    },
    {
      "lang": "en",
      "text": "yet another excellent quarter growing",
      "offset": 244.319,
      "duration": 7.56
    },
    {
      "lang": "en",
      "text": "22% led by growth across all of our",
      "offset": 247.879,
      "duration": 7.241
    },
    {
      "lang": "en",
      "text": "platforms Beyond the top line we",
      "offset": 251.879,
      "duration": 6.121
    },
    {
      "lang": "en",
      "text": "continued to show strong results with",
      "offset": 255.12,
      "duration": 4.119
    },
    {
      "lang": "en",
      "text": "respect to",
      "offset": 258,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "profitability reporting yet another",
      "offset": 259.239,
      "duration": 5.721
    },
    {
      "lang": "en",
      "text": "quarter of improving gross margins and",
      "offset": 261.6,
      "duration": 5.159
    },
    {
      "lang": "en",
      "text": "positive adjusted",
      "offset": 264.96,
      "duration": 4.799
    },
    {
      "lang": "en",
      "text": "EBITA Our performance continues to",
      "offset": 266.759,
      "duration": 5.561
    },
    {
      "lang": "en",
      "text": "highlight that our strategy to drive",
      "offset": 269.759,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "profitable growth in our high margin",
      "offset": 272.32,
      "duration": 6.24
    },
    {
      "lang": "en",
      "text": "large medtech markets is tracking ahead",
      "offset": 275.68,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "of plan resulting in our decision to",
      "offset": 278.56,
      "duration": 6.84
    },
    {
      "lang": "en",
      "text": "increase guidance for the year for total",
      "offset": 282.24,
      "duration": 7.679
    },
    {
      "lang": "en",
      "text": "revenue medtec growth gross margin",
      "offset": 285.4,
      "duration": 8.68
    },
    {
      "lang": "en",
      "text": "adjusted Ibida and adjusted EPS which",
      "offset": 289.919,
      "duration": 7.521
    },
    {
      "lang": "en",
      "text": "Steve will touch upon shortly",
      "offset": 294.08,
      "duration": 6.04
    },
    {
      "lang": "en",
      "text": "Now with an update on our medtech",
      "offset": 297.44,
      "duration": 5.759
    },
    {
      "lang": "en",
      "text": "business Aron continued its sustained",
      "offset": 300.12,
      "duration": 5.96
    },
    {
      "lang": "en",
      "text": "delivery of solid results growing",
      "offset": 303.199,
      "duration": 7.521
    },
    {
      "lang": "en",
      "text": "approximately 17% over the prior year We",
      "offset": 306.08,
      "duration": 7.44
    },
    {
      "lang": "en",
      "text": "have consistently driven revenue growth",
      "offset": 310.72,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "by leveraging our superior technology to",
      "offset": 313.52,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "take share including increasing",
      "offset": 316,
      "duration": 6.08
    },
    {
      "lang": "en",
      "text": "penetration in the hospital market",
      "offset": 318.479,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "Turning to our mechanical throbectomy",
      "offset": 322.08,
      "duration": 5.6
    },
    {
      "lang": "en",
      "text": "business we are very encouraged by the",
      "offset": 324.199,
      "duration": 6.081
    },
    {
      "lang": "en",
      "text": "performance of both alphavvac and",
      "offset": 327.68,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "angiovac which in combination grew",
      "offset": 330.28,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "approximately",
      "offset": 333.24,
      "duration": 5.48
    },
    {
      "lang": "en",
      "text": "47% over the second quarter of last year",
      "offset": 335,
      "duration": 5.8
    },
    {
      "lang": "en",
      "text": "and we believe it further validates the",
      "offset": 338.72,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "strength of this broad innovative",
      "offset": 340.8,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "portfolio",
      "offset": 342.96,
      "duration": 5.48
    },
    {
      "lang": "en",
      "text": "Angiovac and Alphabac together provide",
      "offset": 345.039,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "Angodnamics with an unparalleled product",
      "offset": 348.44,
      "duration": 5.319
    },
    {
      "lang": "en",
      "text": "portfolio option and we continue to",
      "offset": 350.96,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "realize commercial adoption synergies",
      "offset": 353.759,
      "duration": 5.16
    },
    {
      "lang": "en",
      "text": "between these two product",
      "offset": 356.72,
      "duration": 4.36
    },
    {
      "lang": "en",
      "text": "lines Beginning with",
      "offset": 358.919,
      "duration": 5.081
    },
    {
      "lang": "en",
      "text": "Alphabac we saw solid performance in the",
      "offset": 361.08,
      "duration": 7.04
    },
    {
      "lang": "en",
      "text": "quarter with revenue increasing by over",
      "offset": 364,
      "duration": 7.6
    },
    {
      "lang": "en",
      "text": "160% For the fourth quarter in a row",
      "offset": 368.12,
      "duration": 6.44
    },
    {
      "lang": "en",
      "text": "Alphabac has seen sequential growth",
      "offset": 371.6,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "highlighting its accelerating adoption",
      "offset": 374.56,
      "duration": 3.88
    },
    {
      "lang": "en",
      "text": "for treating",
      "offset": 376.72,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "PE We continue to see positive",
      "offset": 378.44,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "utilization trends within existing",
      "offset": 381.36,
      "duration": 5.559
    },
    {
      "lang": "en",
      "text": "customer accounts and just as",
      "offset": 384.16,
      "duration": 5.159
    },
    {
      "lang": "en",
      "text": "importantly we have made significant",
      "offset": 386.919,
      "duration": 5.081
    },
    {
      "lang": "en",
      "text": "strides in growing the number of new",
      "offset": 389.319,
      "duration": 5.641
    },
    {
      "lang": "en",
      "text": "customers reviewing Alphabac within",
      "offset": 392,
      "duration": 6.96
    },
    {
      "lang": "en",
      "text": "their hospital value analysis committees",
      "offset": 394.96,
      "duration": 5.079
    },
    {
      "lang": "en",
      "text": "Turning to",
      "offset": 398.96,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "Angiovac we maintained the strength that",
      "offset": 400.039,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "we exhibited in our second fiscal",
      "offset": 402.639,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "quarter Angiovac contributed revenue of",
      "offset": 405.319,
      "duration": 7.961
    },
    {
      "lang": "en",
      "text": "$6.8 million representing 23% growth",
      "offset": 408.639,
      "duration": 6.361
    },
    {
      "lang": "en",
      "text": "over the prior year",
      "offset": 413.28,
      "duration": 5.039
    },
    {
      "lang": "en",
      "text": "period Angiovac is unique product with a",
      "offset": 415,
      "duration": 6.199
    },
    {
      "lang": "en",
      "text": "compelling value proposition",
      "offset": 418.319,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "In addition as we noted last quarter",
      "offset": 421.199,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "Alphavvac's PE indication has proven to",
      "offset": 424.319,
      "duration": 6.561
    },
    {
      "lang": "en",
      "text": "become a positive catalyst for angiovacc",
      "offset": 427.759,
      "duration": 5.481
    },
    {
      "lang": "en",
      "text": "and our combined mechanical throbectomy",
      "offset": 430.88,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "portfolio We expect to see continued",
      "offset": 433.24,
      "duration": 5.64
    },
    {
      "lang": "en",
      "text": "increasing adoption going forward",
      "offset": 436.08,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "helping to drive sustained growth",
      "offset": 438.88,
      "duration": 4.28
    },
    {
      "lang": "en",
      "text": "throughout this",
      "offset": 441.039,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "portfolio With Aron and our mechanical",
      "offset": 443.16,
      "duration": 5.439
    },
    {
      "lang": "en",
      "text": "throctomy product offerings taken",
      "offset": 446.319,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "together we believe that we have one of",
      "offset": 448.599,
      "duration": 4.361
    },
    {
      "lang": "en",
      "text": "the most innovative cardiovascular",
      "offset": 451.039,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "portfolios available today We are",
      "offset": 452.96,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "excited to provide a deeper dive into",
      "offset": 455.919,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "that portfolio and our plans for the",
      "offset": 458.24,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "future during our virtual cardiovascular",
      "offset": 461.199,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "technology event following this earnings",
      "offset": 464.08,
      "duration": 5.16
    },
    {
      "lang": "en",
      "text": "call",
      "offset": 467.12,
      "duration": 5.199
    },
    {
      "lang": "en",
      "text": "Lastly within our medte segment is Nano",
      "offset": 469.24,
      "duration": 5.639
    },
    {
      "lang": "en",
      "text": "Knife With all of the progress made in",
      "offset": 472.319,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "calendar year 2024 we are in a",
      "offset": 474.879,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "tremendous position to drive more",
      "offset": 477.759,
      "duration": 5.041
    },
    {
      "lang": "en",
      "text": "widespread adoption particularly within",
      "offset": 479.759,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "the urology community as Nanife",
      "offset": 482.8,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "represents a meaningful advancement in",
      "offset": 485.68,
      "duration": 4.359
    },
    {
      "lang": "en",
      "text": "prostate cancer",
      "offset": 488,
      "duration": 5.199
    },
    {
      "lang": "en",
      "text": "treatment In the quarter we continued to",
      "offset": 490.039,
      "duration": 5.241
    },
    {
      "lang": "en",
      "text": "be encouraged by trends in the adoption",
      "offset": 493.199,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "and utilization of Nanomife evidenced by",
      "offset": 495.28,
      "duration": 6.72
    },
    {
      "lang": "en",
      "text": "over 16% growth in probe revenue during",
      "offset": 498.479,
      "duration": 4.681
    },
    {
      "lang": "en",
      "text": "the",
      "offset": 502,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "quarter Having received an expanded",
      "offset": 503.16,
      "duration": 5.479
    },
    {
      "lang": "en",
      "text": "indication for the nanolife system for",
      "offset": 505.919,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "prostate tissue ablation from the FDA in",
      "offset": 508.639,
      "duration": 5.08
    },
    {
      "lang": "en",
      "text": "early December of",
      "offset": 511.919,
      "duration": 4.841
    },
    {
      "lang": "en",
      "text": "2024 we are able to more proactively",
      "offset": 513.719,
      "duration": 6.041
    },
    {
      "lang": "en",
      "text": "market educate and train for the",
      "offset": 516.76,
      "duration": 5.079
    },
    {
      "lang": "en",
      "text": "procedure in ways that we have been",
      "offset": 519.76,
      "duration": 4.28
    },
    {
      "lang": "en",
      "text": "previously unable to do",
      "offset": 521.839,
      "duration": 5.361
    },
    {
      "lang": "en",
      "text": "So a key component of our marketing and",
      "offset": 524.04,
      "duration": 5.799
    },
    {
      "lang": "en",
      "text": "educational efforts is leveraging the",
      "offset": 527.2,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "highquality data generated during our",
      "offset": 529.839,
      "duration": 5.161
    },
    {
      "lang": "en",
      "text": "preserve clinical",
      "offset": 532.76,
      "duration": 5.4
    },
    {
      "lang": "en",
      "text": "study Preserve met its primary",
      "offset": 535,
      "duration": 5.959
    },
    {
      "lang": "en",
      "text": "effectiveness endpoint demonstrating the",
      "offset": 538.16,
      "duration": 5.6
    },
    {
      "lang": "en",
      "text": "performance of the nanomife system for",
      "offset": 540.959,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "the ablation of prostate tissue in",
      "offset": 543.76,
      "duration": 5.92
    },
    {
      "lang": "en",
      "text": "patients with intermediate risk prostate",
      "offset": 546.399,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "cancer",
      "offset": 549.68,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "And just as importantly the study",
      "offset": 551.36,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "demonstrated extremely compelling",
      "offset": 553.92,
      "duration": 5.32
    },
    {
      "lang": "en",
      "text": "quality of life",
      "offset": 556.32,
      "duration": 5.6
    },
    {
      "lang": "en",
      "text": "outcomes We are very encouraged by the",
      "offset": 559.24,
      "duration": 5
    },
    {
      "lang": "en",
      "text": "interest we have seen for nanomife post",
      "offset": 561.92,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "FDA clearance It is important to",
      "offset": 564.24,
      "duration": 5.68
    },
    {
      "lang": "en",
      "text": "highlight that the expanded indication",
      "offset": 567.12,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "was contemplated in our guidance for",
      "offset": 569.92,
      "duration": 3.64
    },
    {
      "lang": "en",
      "text": "fiscal",
      "offset": 572.08,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "2025 and that we don't expect to see a",
      "offset": 573.56,
      "duration": 5.399
    },
    {
      "lang": "en",
      "text": "material inflection and a projected",
      "offset": 576.48,
      "duration": 5.32
    },
    {
      "lang": "en",
      "text": "performance where in the adoption and",
      "offset": 578.959,
      "duration": 5.761
    },
    {
      "lang": "en",
      "text": "utilization until our recently approved",
      "offset": 581.8,
      "duration": 6.76
    },
    {
      "lang": "en",
      "text": "CPT1 code goes into effect and payers",
      "offset": 584.72,
      "duration": 6.08
    },
    {
      "lang": "en",
      "text": "adopt coverage",
      "offset": 588.56,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "The new codes will be effective on",
      "offset": 590.8,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "January 1 of next calendar year As you",
      "offset": 593.279,
      "duration": 7.601
    },
    {
      "lang": "en",
      "text": "are aware reimbursement and coverage is",
      "offset": 597.36,
      "duration": 6.24
    },
    {
      "lang": "en",
      "text": "a highly complex process encompassing",
      "offset": 600.88,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "many stakeholders",
      "offset": 603.6,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "We will continue to work diligently with",
      "offset": 605.6,
      "duration": 5.919
    },
    {
      "lang": "en",
      "text": "our market access team on coverage",
      "offset": 608.08,
      "duration": 6.64
    },
    {
      "lang": "en",
      "text": "coding and payment initiatives striving",
      "offset": 611.519,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "to ensure that reimbursement will be",
      "offset": 614.72,
      "duration": 5.359
    },
    {
      "lang": "en",
      "text": "widely available across both commercial",
      "offset": 617.279,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "and private payers in advance of that",
      "offset": 620.079,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "effective date",
      "offset": 623.2,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "Now turning to our med device segment",
      "offset": 626.079,
      "duration": 7.281
    },
    {
      "lang": "en",
      "text": "Revenue was $40.7 million an increase of",
      "offset": 629.04,
      "duration": 8.32
    },
    {
      "lang": "en",
      "text": "approximately 1% over last year We were",
      "offset": 633.36,
      "duration": 6.159
    },
    {
      "lang": "en",
      "text": "very pleased with the execution of this",
      "offset": 637.36,
      "duration": 6.68
    },
    {
      "lang": "en",
      "text": "team returning med device segment to",
      "offset": 639.519,
      "duration": 8.081
    },
    {
      "lang": "en",
      "text": "growth Beyond our commercial execution",
      "offset": 644.04,
      "duration": 6.12
    },
    {
      "lang": "en",
      "text": "we completed another illustration of our",
      "offset": 647.6,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "sustained profitability",
      "offset": 650.16,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "We reported adjusted IBIDA of $1.3",
      "offset": 652.48,
      "duration": 6.32
    },
    {
      "lang": "en",
      "text": "million during the third quarter",
      "offset": 655.88,
      "duration": 6.28
    },
    {
      "lang": "en",
      "text": "compared to a loss of $3.6 million",
      "offset": 658.8,
      "duration": 6.36
    },
    {
      "lang": "en",
      "text": "during the third quarter of fiscal",
      "offset": 662.16,
      "duration": 7.84
    },
    {
      "lang": "en",
      "text": "2024 In the quarter adjusted EPS was a",
      "offset": 665.16,
      "duration": 7.96
    },
    {
      "lang": "en",
      "text": "loss of 8 cents per share improving from",
      "offset": 670,
      "duration": 6.64
    },
    {
      "lang": "en",
      "text": "a loss of 16 cents per share in fiscal",
      "offset": 673.12,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "2024",
      "offset": 676.64,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "Before turning the call over to Steve",
      "offset": 679.12,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "for a financial review I want to",
      "offset": 681.04,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "highlight the tremendous work being done",
      "offset": 683.36,
      "duration": 5.039
    },
    {
      "lang": "en",
      "text": "by our clinical and regulatory teams to",
      "offset": 685.6,
      "duration": 5.6
    },
    {
      "lang": "en",
      "text": "generate high quality clinical data",
      "offset": 688.399,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "supporting broader adoption of our",
      "offset": 691.2,
      "duration": 6.72
    },
    {
      "lang": "en",
      "text": "technologies With Aron in January we",
      "offset": 693.959,
      "duration": 6.88
    },
    {
      "lang": "en",
      "text": "launched our ambition BTK trial and",
      "offset": 697.92,
      "duration": 6.96
    },
    {
      "lang": "en",
      "text": "registry with the BTK standing for below",
      "offset": 700.839,
      "duration": 8.521
    },
    {
      "lang": "en",
      "text": "the knee As a reminder the Aron laser",
      "offset": 704.88,
      "duration": 6.8
    },
    {
      "lang": "en",
      "text": "can be used to treat all lower extremity",
      "offset": 709.36,
      "duration": 5.52
    },
    {
      "lang": "en",
      "text": "lesion types including below the knee",
      "offset": 711.68,
      "duration": 6.12
    },
    {
      "lang": "en",
      "text": "above the knee and instant",
      "offset": 714.88,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "reinosis This trial will evaluate",
      "offset": 717.8,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "clinical outcomes when treating patients",
      "offset": 720.32,
      "duration": 6.079
    },
    {
      "lang": "en",
      "text": "suffering from critical limb eskeeia",
      "offset": 723.36,
      "duration": 5.919
    },
    {
      "lang": "en",
      "text": "below their knee using Aron in",
      "offset": 726.399,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "combination with standard balloon",
      "offset": 729.279,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "angoplasty",
      "offset": 731.279,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "We believe this rigorous trial which",
      "offset": 733.2,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "builds upon our earlier Aron BTK study",
      "offset": 735.519,
      "duration": 5.241
    },
    {
      "lang": "en",
      "text": "could demonstrate an important",
      "offset": 739.04,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "advancement in the evidence supporting",
      "offset": 740.76,
      "duration": 6.28
    },
    {
      "lang": "en",
      "text": "the benefits of Aron's laser actomy in",
      "offset": 743.2,
      "duration": 7.12
    },
    {
      "lang": "en",
      "text": "achieving acute and long-term procedural",
      "offset": 747.04,
      "duration": 6.799
    },
    {
      "lang": "en",
      "text": "success in a US market where there is an",
      "offset": 750.32,
      "duration": 6.639
    },
    {
      "lang": "en",
      "text": "unmet need potentially driving increased",
      "offset": 753.839,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "adoption of Arion",
      "offset": 756.959,
      "duration": 5.841
    },
    {
      "lang": "en",
      "text": "Additionally we're very pleased with the",
      "offset": 760.399,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "publication of the Apex AV trial results",
      "offset": 762.8,
      "duration": 7.44
    },
    {
      "lang": "en",
      "text": "in J Sky which validated the safety",
      "offset": 766.32,
      "duration": 7.639
    },
    {
      "lang": "en",
      "text": "efficacy and efficiency of our Alphabac",
      "offset": 770.24,
      "duration": 7.2
    },
    {
      "lang": "en",
      "text": "F-185 system for pulmonary embolism",
      "offset": 773.959,
      "duration": 5.161
    },
    {
      "lang": "en",
      "text": "treatment",
      "offset": 777.44,
      "duration": 3.639
    },
    {
      "lang": "en",
      "text": "We are very excited about our",
      "offset": 779.12,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "performance during the third quarter and",
      "offset": 781.079,
      "duration": 4.721
    },
    {
      "lang": "en",
      "text": "throughout fiscal",
      "offset": 783.76,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "2025 Through a combination of continued",
      "offset": 785.8,
      "duration": 5.719
    },
    {
      "lang": "en",
      "text": "investment in topline growth and",
      "offset": 789.12,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "operational efficiency initiatives we",
      "offset": 791.519,
      "duration": 4.241
    },
    {
      "lang": "en",
      "text": "have accelerated our march to",
      "offset": 794.079,
      "duration": 3.281
    },
    {
      "lang": "en",
      "text": "profitability",
      "offset": 795.76,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "We remain in a fantastic position to",
      "offset": 797.36,
      "duration": 5.32
    },
    {
      "lang": "en",
      "text": "drive widespread adoption of our",
      "offset": 800.32,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "portfolio to meet the evolving demands",
      "offset": 802.68,
      "duration": 5.959
    },
    {
      "lang": "en",
      "text": "of healthcare providers and patients",
      "offset": 805.76,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "while at the same time creating value",
      "offset": 808.639,
      "duration": 3.481
    },
    {
      "lang": "en",
      "text": "for our",
      "offset": 810.88,
      "duration": 4.079
    },
    {
      "lang": "en",
      "text": "shareholders With that I'll turn the",
      "offset": 812.12,
      "duration": 5.08
    },
    {
      "lang": "en",
      "text": "call over to Steve Trobridge our",
      "offset": 814.959,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "executive vice president and chief",
      "offset": 817.2,
      "duration": 4.439
    },
    {
      "lang": "en",
      "text": "financial officer to re to review the",
      "offset": 819.04,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "quarter Thanks Jim Good morning",
      "offset": 821.639,
      "duration": 5.401
    },
    {
      "lang": "en",
      "text": "everybody Before I begin I'd like to",
      "offset": 824.48,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "direct everyone to the presentation on",
      "offset": 827.04,
      "duration": 3.359
    },
    {
      "lang": "en",
      "text": "our investor relations website",
      "offset": 828.8,
      "duration": 3.279
    },
    {
      "lang": "en",
      "text": "summarizing the key items from our",
      "offset": 830.399,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "quarterly results As Jim mentioned",
      "offset": 832.079,
      "duration": 4.481
    },
    {
      "lang": "en",
      "text": "unless otherwise noted all metrics and",
      "offset": 834.639,
      "duration": 3.361
    },
    {
      "lang": "en",
      "text": "growth rates mentioned during today's",
      "offset": 836.56,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "call are on a proform basis which",
      "offset": 838,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "exclude the results of the dialysis and",
      "offset": 840,
      "duration": 3.839
    },
    {
      "lang": "en",
      "text": "bioentry businesses that we divested in",
      "offset": 841.76,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "June 2023 the pick and midline products",
      "offset": 843.839,
      "duration": 6.081
    },
    {
      "lang": "en",
      "text": "that we divested in February 2024 and",
      "offset": 846.8,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "the radio frequency and cintre support",
      "offset": 849.92,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "catheter products that we discontinued",
      "offset": 851.76,
      "duration": 2.84
    },
    {
      "lang": "en",
      "text": "in February",
      "offset": 853.36,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "2024 Additionally unless otherwise noted",
      "offset": 854.6,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "all comparisons will be the third fiscal",
      "offset": 858.079,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "quarter of 2025 versus the third fiscal",
      "offset": 860.32,
      "duration": 5.24
    },
    {
      "lang": "en",
      "text": "quarter of",
      "offset": 863.279,
      "duration": 6.161
    },
    {
      "lang": "en",
      "text": "2024 Revenue increased 9.2% to 72",
      "offset": 865.56,
      "duration": 6.279
    },
    {
      "lang": "en",
      "text": "million driven by growth in both our",
      "offset": 869.44,
      "duration": 6.16
    },
    {
      "lang": "en",
      "text": "medte and US med device platforms Medtec",
      "offset": 871.839,
      "duration": 7.761
    },
    {
      "lang": "en",
      "text": "revenue was 31.3 million a 22.2%",
      "offset": 875.6,
      "duration": 6.479
    },
    {
      "lang": "en",
      "text": "increase while med device revenue was",
      "offset": 879.6,
      "duration": 5.799
    },
    {
      "lang": "en",
      "text": "40.7 million a.9%",
      "offset": 882.079,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "increase For the third quarter our",
      "offset": 885.399,
      "duration": 5.081
    },
    {
      "lang": "en",
      "text": "medtech platforms comprised 44% of our",
      "offset": 887.839,
      "duration": 5.521
    },
    {
      "lang": "en",
      "text": "total revenue compared to 39% of total",
      "offset": 890.48,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "revenue a year ago illustrating",
      "offset": 893.36,
      "duration": 4.479
    },
    {
      "lang": "en",
      "text": "sustained execution on our strategy of",
      "offset": 895.6,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "increasing the percentage of our overall",
      "offset": 897.839,
      "duration": 3.761
    },
    {
      "lang": "en",
      "text": "revenue base coming from our medte",
      "offset": 899.76,
      "duration": 5.199
    },
    {
      "lang": "en",
      "text": "segment Our Aron platform contributed",
      "offset": 901.6,
      "duration": 6.96
    },
    {
      "lang": "en",
      "text": "13.9 million in revenue growing 17.3%",
      "offset": 904.959,
      "duration": 6.081
    },
    {
      "lang": "en",
      "text": "compared to last year Aron has now",
      "offset": 908.56,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "delivered doubledigit year-over-year",
      "offset": 911.04,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "growth in each of the 15 consecutive",
      "offset": 912.72,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "quarters following the anniversary of",
      "offset": 914.959,
      "duration": 2.841
    },
    {
      "lang": "en",
      "text": "its",
      "offset": 916.8,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "launch Mechanical throbectomy revenue",
      "offset": 917.8,
      "duration": 4.92
    },
    {
      "lang": "en",
      "text": "which includes Alphavvac and angiovac",
      "offset": 920.56,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "sales increased 46.7%",
      "offset": 922.72,
      "duration": 5.919
    },
    {
      "lang": "en",
      "text": "year-over-year Alphavac revenue was 3",
      "offset": 926.12,
      "duration": 5.92
    },
    {
      "lang": "en",
      "text": "million an increase of 161.4% 4%",
      "offset": 928.639,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "year-over-year and a 20% sequential",
      "offset": 932.04,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "increase over the second quarter of",
      "offset": 934.639,
      "duration": 4.481
    },
    {
      "lang": "en",
      "text": "2025 resulting from the continued",
      "offset": 936.92,
      "duration": 5
    },
    {
      "lang": "en",
      "text": "adoption of Alphabac for PE And we're",
      "offset": 939.12,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "also pleased to see the sustained strong",
      "offset": 941.92,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "performance of Angioac during the",
      "offset": 943.92,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "quarter which generated $6.8 million of",
      "offset": 945.6,
      "duration": 6.039
    },
    {
      "lang": "en",
      "text": "revenue an increase of",
      "offset": 948.48,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "23.1% As Jim mentioned we're continuing",
      "offset": 951.639,
      "duration": 4.44
    },
    {
      "lang": "en",
      "text": "to see synergies between the two product",
      "offset": 954.24,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "offerings demonstrating our ability to",
      "offset": 956.079,
      "duration": 3.841
    },
    {
      "lang": "en",
      "text": "take share in a highly competitive",
      "offset": 958.16,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "market",
      "offset": 959.92,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "Total Nano Knife revenue was 6.3 million",
      "offset": 962.16,
      "duration": 4.52
    },
    {
      "lang": "en",
      "text": "an increase of",
      "offset": 964.8,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "5.3% NanoNife's disposable revenue",
      "offset": 966.68,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "during the quarter increased",
      "offset": 969.12,
      "duration": 4.639
    },
    {
      "lang": "en",
      "text": "16.2% As we've discussed throughout the",
      "offset": 971.48,
      "duration": 4.599
    },
    {
      "lang": "en",
      "text": "year we expected capital sales during",
      "offset": 973.759,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "this year to be approximately half of",
      "offset": 976.079,
      "duration": 4.801
    },
    {
      "lang": "en",
      "text": "what they were in 2024 The capital sales",
      "offset": 977.92,
      "duration": 5.359
    },
    {
      "lang": "en",
      "text": "are performing better than expected",
      "offset": 980.88,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "declining 21.6% during the quarter and",
      "offset": 983.279,
      "duration": 6.24
    },
    {
      "lang": "en",
      "text": "down 26.5% year-to- date",
      "offset": 986.24,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "We're particularly pleased with the",
      "offset": 989.519,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "trajectory of prostate cases in the",
      "offset": 990.959,
      "duration": 3.361
    },
    {
      "lang": "en",
      "text": "quarter and are on track for our",
      "offset": 992.639,
      "duration": 3.56
    },
    {
      "lang": "en",
      "text": "projections for Nano Knife for the full",
      "offset": 994.32,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "year As a reminder while we expect to",
      "offset": 996.199,
      "duration": 4.841
    },
    {
      "lang": "en",
      "text": "see increasing contribution from Nano",
      "offset": 999.12,
      "duration": 3.279
    },
    {
      "lang": "en",
      "text": "Knife following the positive",
      "offset": 1001.04,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "reimbursement decision and prostate",
      "offset": 1002.399,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "indication received towards the end of",
      "offset": 1004.16,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "calendar 24 these milestones were built",
      "offset": 1005.839,
      "duration": 5.841
    },
    {
      "lang": "en",
      "text": "into our expectations for FY25 and are",
      "offset": 1008.72,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "already reflected in our guidance for",
      "offset": 1011.68,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "the year",
      "offset": 1013.12,
      "duration": 4.079
    },
    {
      "lang": "en",
      "text": "Moving down the income statement gross",
      "offset": 1015.199,
      "duration": 5.521
    },
    {
      "lang": "en",
      "text": "margin was 54% an increase of 290 basis",
      "offset": 1017.199,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "points compared to the year ago period",
      "offset": 1020.72,
      "duration": 3.8
    },
    {
      "lang": "en",
      "text": "and ahead of our expectations for the",
      "offset": 1022.639,
      "duration": 4.92
    },
    {
      "lang": "en",
      "text": "quarter Medtech gross margin was",
      "offset": 1024.52,
      "duration": 6.36
    },
    {
      "lang": "en",
      "text": "62.5% an increase of 100 basis points",
      "offset": 1027.559,
      "duration": 5.721
    },
    {
      "lang": "en",
      "text": "primarily driven by mix associated with",
      "offset": 1030.88,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "increased angiovac revenue and Aron's",
      "offset": 1033.28,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "increasing penetration into the hospital",
      "offset": 1035.839,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "side of care Med device gross margin was",
      "offset": 1037.839,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "47.4%",
      "offset": 1040.959,
      "duration": 4.801
    },
    {
      "lang": "en",
      "text": "In a moment I will discuss our increased",
      "offset": 1043.839,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "guidance for the balance of our fiscal",
      "offset": 1045.76,
      "duration": 3.039
    },
    {
      "lang": "en",
      "text": "year including our increased",
      "offset": 1047.28,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "expectations for gross margins I do want",
      "offset": 1048.799,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "to take a quick moment to discuss the",
      "offset": 1051.2,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "macro environment and potential tariffs",
      "offset": 1052.72,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "We're keeping a close eye on the ever",
      "offset": 1055.52,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "evolving tariff situation and like most",
      "offset": 1057.12,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "of you we don't have a concrete",
      "offset": 1058.96,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "projection on where this will all end",
      "offset": 1060.88,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "While we do have a small amount of",
      "offset": 1063.2,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "subcomponent suppliers that may become",
      "offset": 1064.64,
      "duration": 4.159
    },
    {
      "lang": "en",
      "text": "subject to tariffs we do not believe",
      "offset": 1066.48,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "today that tariffs will materially",
      "offset": 1068.799,
      "duration": 3.601
    },
    {
      "lang": "en",
      "text": "impact our business Now we've",
      "offset": 1070.4,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "historically manufactured the vast",
      "offset": 1072.4,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "majority of our products in the US and",
      "offset": 1073.919,
      "duration": 4.361
    },
    {
      "lang": "en",
      "text": "most of our suppliers are also",
      "offset": 1076.16,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "US-based We're currently executing on",
      "offset": 1078.28,
      "duration": 3.96
    },
    {
      "lang": "en",
      "text": "our manufacturing transition plan but",
      "offset": 1080.4,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "this plan has never included moves to",
      "offset": 1082.24,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "areas such as Mexico or China We'll",
      "offset": 1083.919,
      "duration": 4.241
    },
    {
      "lang": "en",
      "text": "continue to monitor this dynamic",
      "offset": 1086.72,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "situation and provide appropriate",
      "offset": 1088.16,
      "duration": 5.08
    },
    {
      "lang": "en",
      "text": "updates as they develop with any",
      "offset": 1089.84,
      "duration": 6.4
    },
    {
      "lang": "en",
      "text": "clarity Turning to R&amp;D our research and",
      "offset": 1093.24,
      "duration": 5.559
    },
    {
      "lang": "en",
      "text": "development expense was 6.9 million or",
      "offset": 1096.24,
      "duration": 6.24
    },
    {
      "lang": "en",
      "text": "9.6% 6% of sales compared to 8.1 million",
      "offset": 1098.799,
      "duration": 7.201
    },
    {
      "lang": "en",
      "text": "or 12.2% of sales a year ago The",
      "offset": 1102.48,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "year-over-year decrease is primarily",
      "offset": 1106,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "related to timing including the",
      "offset": 1107.76,
      "duration": 3.279
    },
    {
      "lang": "en",
      "text": "completion of our preserve and apex",
      "offset": 1109.52,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "clinical studies We remain committed to",
      "offset": 1111.039,
      "duration": 4.801
    },
    {
      "lang": "en",
      "text": "investing in R&amp;D initiatives to support",
      "offset": 1113.76,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "the long-term growth of our medte",
      "offset": 1115.84,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "segment and are targeting approximately",
      "offset": 1117.52,
      "duration": 4.36
    },
    {
      "lang": "en",
      "text": "10% of sales going",
      "offset": 1119.6,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "forward SGNA expense was 36 million",
      "offset": 1121.88,
      "duration": 6.2
    },
    {
      "lang": "en",
      "text": "representing 50% of sales compared to",
      "offset": 1125.44,
      "duration": 7.239
    },
    {
      "lang": "en",
      "text": "34.2 2 million or 51.9% of sales a year",
      "offset": 1128.08,
      "duration": 7.599
    },
    {
      "lang": "en",
      "text": "ago Our adjusted net loss was 3.1",
      "offset": 1132.679,
      "duration": 5.401
    },
    {
      "lang": "en",
      "text": "million or an adjusted loss per share of",
      "offset": 1135.679,
      "duration": 5.281
    },
    {
      "lang": "en",
      "text": "8 cents compared to an adjusted net loss",
      "offset": 1138.08,
      "duration": 5.839
    },
    {
      "lang": "en",
      "text": "of 6.5 million or adjusted loss per",
      "offset": 1140.96,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "share of 16 cents in the third quarter",
      "offset": 1143.919,
      "duration": 3.081
    },
    {
      "lang": "en",
      "text": "of last",
      "offset": 1146.08,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "year The year-over-year improvement is",
      "offset": 1147,
      "duration": 4.6
    },
    {
      "lang": "en",
      "text": "largely attributable to higher revenue",
      "offset": 1149.44,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "and improving operating leverage during",
      "offset": 1151.6,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "the third quarter of this year",
      "offset": 1153.44,
      "duration": 5.359
    },
    {
      "lang": "en",
      "text": "Adjusted EBIDA was 1.3 million compared",
      "offset": 1155.84,
      "duration": 6.44
    },
    {
      "lang": "en",
      "text": "to a loss of 3.6 million in the prior",
      "offset": 1158.799,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "year Turning now to an update on our",
      "offset": 1162.28,
      "duration": 5.72
    },
    {
      "lang": "en",
      "text": "balance sheet At February 28 2025 we had",
      "offset": 1164.559,
      "duration": 5.881
    },
    {
      "lang": "en",
      "text": "44.8 million in cash and cash",
      "offset": 1168,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "equivalents In the quarter we used 13.2",
      "offset": 1170.44,
      "duration": 4.92
    },
    {
      "lang": "en",
      "text": "million in operating cash had capital",
      "offset": 1173.44,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "expenditures of 1.8 million and",
      "offset": 1175.36,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "additions to ARN placement and",
      "offset": 1177.76,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "evaluation units of 1.4 million",
      "offset": 1179.28,
      "duration": 5.759
    },
    {
      "lang": "en",
      "text": "As expected we utilized total cash on",
      "offset": 1182.48,
      "duration": 4.319
    },
    {
      "lang": "en",
      "text": "the balance sheet of approximately 10",
      "offset": 1185.039,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "million largely driven by scheduled",
      "offset": 1186.799,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "payments associated with the settlement",
      "offset": 1189.2,
      "duration": 3.599
    },
    {
      "lang": "en",
      "text": "of our patent litigation with BDBR that",
      "offset": 1190.88,
      "duration": 4.159
    },
    {
      "lang": "en",
      "text": "we executed last year and working",
      "offset": 1192.799,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "capital usage connected with our",
      "offset": 1195.039,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "transition manufacturing arrangement",
      "offset": 1196.88,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "with Spectrum Vascular the company we",
      "offset": 1198.48,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "sold our pick and midline business to in",
      "offset": 1200.559,
      "duration": 3.24
    },
    {
      "lang": "en",
      "text": "February of last",
      "offset": 1202.4,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "year In the fourth quarter we expect to",
      "offset": 1203.799,
      "duration": 4.201
    },
    {
      "lang": "en",
      "text": "generate cash and end the year with",
      "offset": 1206.32,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "approximately 55 million in cash and",
      "offset": 1208,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "cash equivalents Now the primary",
      "offset": 1210,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "variable associated with our cash",
      "offset": 1212.08,
      "duration": 3.839
    },
    {
      "lang": "en",
      "text": "projection is related to the transition",
      "offset": 1213.76,
      "duration": 4.2
    },
    {
      "lang": "en",
      "text": "manufacturing arrangement I just",
      "offset": 1215.919,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "mentioned As we discussed on our last",
      "offset": 1217.96,
      "duration": 4.04
    },
    {
      "lang": "en",
      "text": "earnings call subsequent to our third",
      "offset": 1220.08,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "quarter end we secured a commitment from",
      "offset": 1222,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "JP Morgan to provide us with a revolving",
      "offset": 1223.84,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "line of credit agreement We expect to",
      "offset": 1225.919,
      "duration": 3.841
    },
    {
      "lang": "en",
      "text": "close this facility in the next few",
      "offset": 1228.4,
      "duration": 2.96
    },
    {
      "lang": "en",
      "text": "weeks which will give us the ability to",
      "offset": 1229.76,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "draw up to 25 million in cash at our",
      "offset": 1231.36,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "discretion While we are very comfortable",
      "offset": 1233.52,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "with the amount of cash we have on the",
      "offset": 1236,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "balance sheet we view the addition of a",
      "offset": 1237.36,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "revolver as a matter of prudent",
      "offset": 1239.36,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "financial housekeeping and a good safety",
      "offset": 1241.12,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "net to ensure that any short-term",
      "offset": 1243.28,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "working capital fluctuations associated",
      "offset": 1244.88,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "with the spectrum transition",
      "offset": 1246.96,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "manufacturing agreement doesn't impact",
      "offset": 1248.24,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "our execution on our strategy We believe",
      "offset": 1250.32,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "that this revolver will further bolster",
      "offset": 1253.12,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "our balance sheet and provides for",
      "offset": 1255.36,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "increased flexibility and optionality at",
      "offset": 1257.44,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "a relatively low cost of capital and",
      "offset": 1259.919,
      "duration": 5.361
    },
    {
      "lang": "en",
      "text": "zero dilution Now finally we remain on",
      "offset": 1261.84,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "track with our stated goal of being cash",
      "offset": 1265.28,
      "duration": 5
    },
    {
      "lang": "en",
      "text": "flow positive for the full fiscal year",
      "offset": 1267.28,
      "duration": 5.279
    },
    {
      "lang": "en",
      "text": "2026 We're very pleased with our",
      "offset": 1270.28,
      "duration": 4.279
    },
    {
      "lang": "en",
      "text": "execution in managing our balance sheet",
      "offset": 1272.559,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "through our strategic transition in a",
      "offset": 1274.559,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "dynamic macro environment We're in a",
      "offset": 1276.72,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "very strong position driving",
      "offset": 1279.52,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "double-digit growth in our medte segment",
      "offset": 1280.96,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "with sufficient net cash position on our",
      "offset": 1283.36,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "balance sheet a P&amp;L that is delivering",
      "offset": 1285.44,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "positive adjusted EBID each quarter and",
      "offset": 1287.919,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "an overall business model that will",
      "offset": 1290.4,
      "duration": 3.279
    },
    {
      "lang": "en",
      "text": "generate positive cash for the upcoming",
      "offset": 1291.919,
      "duration": 2.921
    },
    {
      "lang": "en",
      "text": "year and",
      "offset": 1293.679,
      "duration": 3.681
    },
    {
      "lang": "en",
      "text": "beyond So turning now to guidance for",
      "offset": 1294.84,
      "duration": 5.64
    },
    {
      "lang": "en",
      "text": "fiscal 2025 we now expect revenue will",
      "offset": 1297.36,
      "duration": 6.319
    },
    {
      "lang": "en",
      "text": "be in the range of 285 million to 288",
      "offset": 1300.48,
      "duration": 5.559
    },
    {
      "lang": "en",
      "text": "million representing growth of between",
      "offset": 1303.679,
      "duration": 6.681
    },
    {
      "lang": "en",
      "text": "5.3% and 6.4% 4% over fiscal year",
      "offset": 1306.039,
      "duration": 6.76
    },
    {
      "lang": "en",
      "text": "2024 Within each of our businesses we",
      "offset": 1310.36,
      "duration": 4.92
    },
    {
      "lang": "en",
      "text": "now expect med tech net sales to grow in",
      "offset": 1312.799,
      "duration": 5.041
    },
    {
      "lang": "en",
      "text": "the range of 14 to 16% ahead of our",
      "offset": 1315.28,
      "duration": 4.84
    },
    {
      "lang": "en",
      "text": "previously updated guidance of 12 to",
      "offset": 1317.84,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "15% And we continue to expect med device",
      "offset": 1320.12,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "net sales to be",
      "offset": 1322.88,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "flat From a quarterly cadence",
      "offset": 1324.679,
      "duration": 4.12
    },
    {
      "lang": "en",
      "text": "perspective we expect the fourth quarter",
      "offset": 1326.799,
      "duration": 4.481
    },
    {
      "lang": "en",
      "text": "to be the strongest of the fiscal year",
      "offset": 1328.799,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "For fiscal 2025 we now expect gross",
      "offset": 1331.28,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "margin to be in the range of 53 to 54%",
      "offset": 1333.76,
      "duration": 6.44
    },
    {
      "lang": "en",
      "text": "up from the previous guidance of 52 to",
      "offset": 1337.12,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "53% We now expect adjusted EBID dot in",
      "offset": 1340.2,
      "duration": 5.4
    },
    {
      "lang": "en",
      "text": "the range of 4 million to 5 million up",
      "offset": 1343.12,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "from the previously updated guidance of",
      "offset": 1345.6,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "1 to 3 million And finally we now expect",
      "offset": 1347.36,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "an adjusted loss per share in the range",
      "offset": 1350.72,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "of 31 to 34 cents an improvement from",
      "offset": 1352.72,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "our previously updated guidance of a",
      "offset": 1355.76,
      "duration": 5.52
    },
    {
      "lang": "en",
      "text": "loss per share of 34 to 38 cents",
      "offset": 1357.679,
      "duration": 6.161
    },
    {
      "lang": "en",
      "text": "With that I'll turn it back to Jim",
      "offset": 1361.28,
      "duration": 5.279
    },
    {
      "lang": "en",
      "text": "Thanks Steve Looking to the fourth",
      "offset": 1363.84,
      "duration": 5.52
    },
    {
      "lang": "en",
      "text": "quarter we remain focused on a number of",
      "offset": 1366.559,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "key strategic areas of our business",
      "offset": 1369.36,
      "duration": 5.64
    },
    {
      "lang": "en",
      "text": "aimed at driving growth Starting with",
      "offset": 1371.679,
      "duration": 6.401
    },
    {
      "lang": "en",
      "text": "Aron in the US we will leverage the",
      "offset": 1375,
      "duration": 5.4
    },
    {
      "lang": "en",
      "text": "momentum built during the first three",
      "offset": 1378.08,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "quarters of the year to continue to",
      "offset": 1380.4,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "drive increased penetration with a",
      "offset": 1382.799,
      "duration": 6.161
    },
    {
      "lang": "en",
      "text": "particular focus on the hospital setting",
      "offset": 1385.28,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "outside of the US We expect a full",
      "offset": 1388.96,
      "duration": 5.839
    },
    {
      "lang": "en",
      "text": "market release following our CE marking",
      "offset": 1391.84,
      "duration": 6.56
    },
    {
      "lang": "en",
      "text": "in Q1 to make a positive impact on",
      "offset": 1394.799,
      "duration": 6.721
    },
    {
      "lang": "en",
      "text": "revenue during the fourth quarter We",
      "offset": 1398.4,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "will continue to develop supporting",
      "offset": 1401.52,
      "duration": 4.639
    },
    {
      "lang": "en",
      "text": "clinical data and launching new product",
      "offset": 1403.44,
      "duration": 6.599
    },
    {
      "lang": "en",
      "text": "line extensions As we move forward with",
      "offset": 1406.159,
      "duration": 6.241
    },
    {
      "lang": "en",
      "text": "Alphabac we continue to push ahead",
      "offset": 1410.039,
      "duration": 4.76
    },
    {
      "lang": "en",
      "text": "commercially as we focus on driving",
      "offset": 1412.4,
      "duration": 5.56
    },
    {
      "lang": "en",
      "text": "increased adoption for the treatment of",
      "offset": 1414.799,
      "duration": 6.721
    },
    {
      "lang": "en",
      "text": "PE To support that we will continue to",
      "offset": 1417.96,
      "duration": 6.52
    },
    {
      "lang": "en",
      "text": "invest in high quality clinical data",
      "offset": 1421.52,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "highlighting the differentation of our",
      "offset": 1424.48,
      "duration": 5.439
    },
    {
      "lang": "en",
      "text": "products to help support long-term",
      "offset": 1427.36,
      "duration": 6.72
    },
    {
      "lang": "en",
      "text": "adoption In addition we continue to",
      "offset": 1429.919,
      "duration": 6.041
    },
    {
      "lang": "en",
      "text": "expect to launch new product",
      "offset": 1434.08,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "enhancements over the course of the year",
      "offset": 1435.96,
      "duration": 6.599
    },
    {
      "lang": "en",
      "text": "to further enhance our product And",
      "offset": 1438.96,
      "duration": 6.16
    },
    {
      "lang": "en",
      "text": "lastly with nano knife with prostate",
      "offset": 1442.559,
      "duration": 5.841
    },
    {
      "lang": "en",
      "text": "indication in hand as well as clarity",
      "offset": 1445.12,
      "duration": 5.28
    },
    {
      "lang": "en",
      "text": "around the reimbursement pathway in the",
      "offset": 1448.4,
      "duration": 4.879
    },
    {
      "lang": "en",
      "text": "US we expect to leverage a",
      "offset": 1450.4,
      "duration": 4.36
    },
    {
      "lang": "en",
      "text": "wellestablished commercial",
      "offset": 1453.279,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "infrastructure and our high quality",
      "offset": 1454.76,
      "duration": 5.24
    },
    {
      "lang": "en",
      "text": "clinical data to drive increased",
      "offset": 1457.039,
      "duration": 5.921
    },
    {
      "lang": "en",
      "text": "long-term adoption in the US for",
      "offset": 1460,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "prostate",
      "offset": 1462.96,
      "duration": 4.319
    },
    {
      "lang": "en",
      "text": "I would like to remind everyone that we",
      "offset": 1464.88,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "will be hosting a virtual cardiovascular",
      "offset": 1467.279,
      "duration": 6.961
    },
    {
      "lang": "en",
      "text": "specific event at 9:00 Eastern today to",
      "offset": 1469.84,
      "duration": 7.12
    },
    {
      "lang": "en",
      "text": "provide an indepth overview on our",
      "offset": 1474.24,
      "duration": 5.64
    },
    {
      "lang": "en",
      "text": "cardiovascular franchise including our",
      "offset": 1476.96,
      "duration": 7.36
    },
    {
      "lang": "en",
      "text": "Aron Angio and Alphabac technologies our",
      "offset": 1479.88,
      "duration": 7.24
    },
    {
      "lang": "en",
      "text": "respective market opportunities and our",
      "offset": 1484.32,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "strategic vision for these products",
      "offset": 1487.12,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "moving forward",
      "offset": 1489.36,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "In summary we remain very excited about",
      "offset": 1491.52,
      "duration": 6.32
    },
    {
      "lang": "en",
      "text": "the future at Angio Dynamics We have",
      "offset": 1495.12,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "built a fantastic portfolio focused on",
      "offset": 1497.84,
      "duration": 6.319
    },
    {
      "lang": "en",
      "text": "large high- growth markets We have",
      "offset": 1501.12,
      "duration": 5.76
    },
    {
      "lang": "en",
      "text": "overhauled our financial profile and",
      "offset": 1504.159,
      "duration": 5.041
    },
    {
      "lang": "en",
      "text": "with the strength of our balance sheet",
      "offset": 1506.88,
      "duration": 5.32
    },
    {
      "lang": "en",
      "text": "we are on the verge of delivering",
      "offset": 1509.2,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "sustainable profitable growth for years",
      "offset": 1512.2,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "to",
      "offset": 1515.2,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "come With that we'll open the line for",
      "offset": 1515.96,
      "duration": 6.199
    },
    {
      "lang": "en",
      "text": "questions",
      "offset": 1519.52,
      "duration": 4.159
    },
    {
      "lang": "en",
      "text": "Thank you At this time we'll be",
      "offset": 1522.159,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "conducting a question and answer session",
      "offset": 1523.679,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "If you'd like to ask a question please",
      "offset": 1525.919,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "press star one on your telephone keypad",
      "offset": 1527.84,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "A confirmation tone will indicate your",
      "offset": 1530.559,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "line is in the question queue You may",
      "offset": 1532.32,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "press star two if you'd like to remove",
      "offset": 1534.88,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "your question from the queue For",
      "offset": 1536.88,
      "duration": 4.159
    },
    {
      "lang": "en",
      "text": "participants using speaker equipment it",
      "offset": 1539.2,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "may be necessary to pick up your handset",
      "offset": 1541.039,
      "duration": 4.561
    },
    {
      "lang": "en",
      "text": "before pressing the star keys One moment",
      "offset": 1543.12,
      "duration": 5.24
    },
    {
      "lang": "en",
      "text": "please while we pull for",
      "offset": 1545.6,
      "duration": 6.16
    },
    {
      "lang": "en",
      "text": "questions Okay",
      "offset": 1548.36,
      "duration": 3.4
    },
    {
      "lang": "en",
      "text": "Thank you Our first question comes from",
      "offset": 1552.559,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "the line of John Young with Cancord",
      "offset": 1554.4,
      "duration": 4.2
    },
    {
      "lang": "en",
      "text": "Genuity Please proceed with your",
      "offset": 1556.48,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "question Uh hi Jim and Steve thanks for",
      "offset": 1558.6,
      "duration": 3.72
    },
    {
      "lang": "en",
      "text": "taking the question and congrats on a",
      "offset": 1560.88,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "great quarter Yeah I just want to start",
      "offset": 1562.32,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "first on Angiovak Um you know still",
      "offset": 1564,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "remain strong which was nice to see just",
      "offset": 1566.4,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "you know despite the the very strong",
      "offset": 1568.32,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "quarter you had last quarter Do you",
      "offset": 1570.64,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "think the $6.8 million is is a good new",
      "offset": 1572.64,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "base that we should think about for the",
      "offset": 1575.6,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "business going forward and I have one",
      "offset": 1577.2,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "followup Thanks Yeah thanks John Good to",
      "offset": 1579.2,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "talk you this morning Yeah the answer is",
      "offset": 1582,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "yes I think as we talked about last",
      "offset": 1584.32,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "quarter we were very pleased with the",
      "offset": 1585.919,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "performance we saw with Angiovac and",
      "offset": 1587.44,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "particularly we're pleased with the",
      "offset": 1589.84,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "synergistic portfolio that we have with",
      "offset": 1591.679,
      "duration": 5.201
    },
    {
      "lang": "en",
      "text": "Angioac together with the Alphabac PE Uh",
      "offset": 1593.76,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "we're seeing that our conversations with",
      "offset": 1596.88,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "interventional cardiologists are driving",
      "offset": 1598.96,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "increased awareness of our over",
      "offset": 1600.96,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "portfolio of our overall portfolio and",
      "offset": 1602.48,
      "duration": 4.079
    },
    {
      "lang": "en",
      "text": "certainly leading to to good performance",
      "offset": 1604.88,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "from both So as we said last quarter we",
      "offset": 1606.559,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "expect Angioc will be a grower for us",
      "offset": 1609.12,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "Now maybe not at these same growth rates",
      "offset": 1611.52,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "but I think this level uh you know kind",
      "offset": 1614.24,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "of mid6s and seeing that as a growth",
      "offset": 1616.32,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "platform moving forward is the right way",
      "offset": 1618.799,
      "duration": 3.601
    },
    {
      "lang": "en",
      "text": "to think about angiovac going forward",
      "offset": 1620.48,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "And as we said we expect you're going to",
      "offset": 1622.4,
      "duration": 3.04
    },
    {
      "lang": "en",
      "text": "see increasing growth coming from",
      "offset": 1624,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "Alphabac uh as we continue to see",
      "offset": 1625.44,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "further adoption for our products for PE",
      "offset": 1627.44,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "cases",
      "offset": 1629.679,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "Okay great Thanks And then just on",
      "offset": 1632.08,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "nanized prostate um you know any further",
      "offset": 1634,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "details you could share with us just on",
      "offset": 1636.72,
      "duration": 3.04
    },
    {
      "lang": "en",
      "text": "you know percentage of revenue that's",
      "offset": 1638.48,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "attributable to prostate in the quarter",
      "offset": 1639.76,
      "duration": 5.039
    },
    {
      "lang": "en",
      "text": "um any KPIs from your direct to consumer",
      "offset": 1642.159,
      "duration": 4.721
    },
    {
      "lang": "en",
      "text": "you know education or physician efforts",
      "offset": 1644.799,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "that you've you've started with the",
      "offset": 1646.88,
      "duration": 4.159
    },
    {
      "lang": "en",
      "text": "marketing approval um and then for the",
      "offset": 1648.88,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "CPT level one code should we still think",
      "offset": 1651.039,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "of July as being kind of the first",
      "offset": 1653.36,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "update into what the possible",
      "offset": 1655.039,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "reimbursement for next year looks like",
      "offset": 1656.88,
      "duration": 4.56
    },
    {
      "lang": "en",
      "text": "thanks again for taking our questions",
      "offset": 1658.96,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "Yeah Hi John It's Jim Uh a couple",
      "offset": 1661.44,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "questions Yeah we started our awareness",
      "offset": 1663.84,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "and education campaign as you know right",
      "offset": 1665.76,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "after we got the approval from the FDA",
      "offset": 1668.24,
      "duration": 5.52
    },
    {
      "lang": "en",
      "text": "um for the prostate um market So we're",
      "offset": 1670.96,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "excited by the response we've seen you",
      "offset": 1673.76,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "know some from individual patients who",
      "offset": 1675.679,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "are trying to learn about their",
      "offset": 1677.679,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "treatment pathways and options that",
      "offset": 1679.279,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "exist So that's been really kind of fun",
      "offset": 1681.039,
      "duration": 4.481
    },
    {
      "lang": "en",
      "text": "to watch new people learn about this new",
      "offset": 1683.039,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "option that we offer also with",
      "offset": 1685.52,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "physicians people signing up for our",
      "offset": 1687.679,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "training programs getting involved",
      "offset": 1689.52,
      "duration": 2.72
    },
    {
      "lang": "en",
      "text": "wanting to learn how to use this",
      "offset": 1691.039,
      "duration": 3.201
    },
    {
      "lang": "en",
      "text": "technology bring it in house as part of",
      "offset": 1692.24,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "their treatment protocol So really",
      "offset": 1694.24,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "really good organic metric uh metrics we",
      "offset": 1695.919,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "track We don't share all those for",
      "offset": 1698.72,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "competitive reasons but we also measure",
      "offset": 1700,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "every month the procedures that we use",
      "offset": 1702.24,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "with nano knife And I think we've talked",
      "offset": 1703.76,
      "duration": 4.399
    },
    {
      "lang": "en",
      "text": "about it before increasing percentages",
      "offset": 1705.76,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "each month go by with prostates being",
      "offset": 1708.159,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "treated at a higher and higher rate It's",
      "offset": 1710.48,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "now more than half of our treatments",
      "offset": 1712.08,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "liver and pancreas as you know are the",
      "offset": 1713.76,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "second and third Um but for years",
      "offset": 1715.44,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "prostate was third behind them It's",
      "offset": 1717.2,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "become number one and it grows each",
      "offset": 1718.72,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "month at a higher and higher rate of",
      "offset": 1720.64,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "treatment So we're really excited by the",
      "offset": 1722.399,
      "duration": 3.841
    },
    {
      "lang": "en",
      "text": "organic interest being created Yeah And",
      "offset": 1724.159,
      "duration": 3.281
    },
    {
      "lang": "en",
      "text": "John getting to your question on",
      "offset": 1726.24,
      "duration": 2.559
    },
    {
      "lang": "en",
      "text": "reimbursement It's the exact right",
      "offset": 1727.44,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "question As we've always said there's",
      "offset": 1728.799,
      "duration": 2.961
    },
    {
      "lang": "en",
      "text": "really three pillars that are going to",
      "offset": 1730.32,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "drive nano knife growth going forward It",
      "offset": 1731.76,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "was important for us to get the specific",
      "offset": 1733.76,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "indication that's kind of table stakes",
      "offset": 1735.279,
      "duration": 4.561
    },
    {
      "lang": "en",
      "text": "We were able to do that uh in December",
      "offset": 1737.12,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "Uh the second one is increased awareness",
      "offset": 1739.84,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "and Jim just talked about that We're",
      "offset": 1741.76,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "really pleased with the uptick in",
      "offset": 1743.2,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "interest that we're seeing with respect",
      "offset": 1745.44,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "to Nano Knife coming on the heels of",
      "offset": 1747.2,
      "duration": 3.359
    },
    {
      "lang": "en",
      "text": "getting the indication and certainly the",
      "offset": 1748.96,
      "duration": 3.599
    },
    {
      "lang": "en",
      "text": "event that we did last quarter And then",
      "offset": 1750.559,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "the third and the most important in",
      "offset": 1752.559,
      "duration": 3.041
    },
    {
      "lang": "en",
      "text": "terms of driving adoption and getting to",
      "offset": 1753.919,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "that inflection point is going to be",
      "offset": 1755.6,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "reimbursement We're still on track to",
      "offset": 1757.039,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "hear the first readout uh in in the",
      "offset": 1758.88,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "summer in July and then we expect that",
      "offset": 1761.279,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "that uh CPT1 code will become permanent",
      "offset": 1762.96,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "in January And so we're doing the work",
      "offset": 1765.679,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "you would expect us to do now uh",
      "offset": 1767.84,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "continuing to kind of beat beat the the",
      "offset": 1769.76,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "ground and and uh and try to increase",
      "offset": 1771.76,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "the amount of those private payers that",
      "offset": 1774,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "are going to be covering once we get to",
      "offset": 1775.76,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "that permanent code So we'll continue to",
      "offset": 1777.12,
      "duration": 3.039
    },
    {
      "lang": "en",
      "text": "do that work We'll update you as we move",
      "offset": 1778.64,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "forward but yes the way that you're",
      "offset": 1780.159,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "talking about it is exactly right Expect",
      "offset": 1782.08,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "the first readout in the summer and that",
      "offset": 1783.6,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "code to go into effect in January",
      "offset": 1784.96,
      "duration": 6.599
    },
    {
      "lang": "en",
      "text": "Thanks again",
      "offset": 1788.32,
      "duration": 3.239
    },
    {
      "lang": "en",
      "text": "Thank you Our next question comes from",
      "offset": 1792.64,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "the line of Steven Lickman with",
      "offset": 1794.48,
      "duration": 3.439
    },
    {
      "lang": "en",
      "text": "Oenheimer and Company Please proceed",
      "offset": 1796.159,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "with your question",
      "offset": 1797.919,
      "duration": 3.88
    },
    {
      "lang": "en",
      "text": "Thank you Good morning guys and",
      "offset": 1800.08,
      "duration": 4.479
    },
    {
      "lang": "en",
      "text": "congratulations Um just wanted to also",
      "offset": 1801.799,
      "duration": 4.841
    },
    {
      "lang": "en",
      "text": "ask on MT you know given the strength",
      "offset": 1804.559,
      "duration": 4.641
    },
    {
      "lang": "en",
      "text": "you're seeing in angiovac post the",
      "offset": 1806.64,
      "duration": 4.639
    },
    {
      "lang": "en",
      "text": "alphabac launch Can can you give us an",
      "offset": 1809.2,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "update on your commercial efforts across",
      "offset": 1811.279,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "mechanical probectomy uh I know",
      "offset": 1813.12,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "initially you're working through where",
      "offset": 1815.039,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "the team focused obviously you're seeing",
      "offset": 1816.96,
      "duration": 5.52
    },
    {
      "lang": "en",
      "text": "success Um are you looking to further",
      "offset": 1819.919,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "add to the commercial team or are you",
      "offset": 1822.48,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "feeling good about sort of the coverage",
      "offset": 1824.159,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "going after Alphabac and keeping this",
      "offset": 1826.08,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "angiovac momentum going yeah thanks",
      "offset": 1828.159,
      "duration": 5.361
    },
    {
      "lang": "en",
      "text": "Steve So as we we've spoke previously",
      "offset": 1831.44,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "our team did a really good job targeting",
      "offset": 1833.52,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "where our first batch of sales",
      "offset": 1835.36,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "professionals would be located as we",
      "offset": 1837.12,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "were expecting that PE indication and",
      "offset": 1838.88,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "launch for the AlphaVAC uh product So we",
      "offset": 1841.2,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "did that We've got the right people in",
      "offset": 1844.08,
      "duration": 2.64
    },
    {
      "lang": "en",
      "text": "the right places that we thought were",
      "offset": 1845.52,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "the 40 or so starting markets we wanted",
      "offset": 1846.72,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "to be in and that's going really well as",
      "offset": 1849.52,
      "duration": 3.039
    },
    {
      "lang": "en",
      "text": "you're seeing the effect of both",
      "offset": 1851.44,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "products being sold together as well The",
      "offset": 1852.559,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "team is good They're well trained and",
      "offset": 1854.32,
      "duration": 3.599
    },
    {
      "lang": "en",
      "text": "they're educated now uh to serve our",
      "offset": 1855.919,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "customers We also talked about us",
      "offset": 1857.919,
      "duration": 3.601
    },
    {
      "lang": "en",
      "text": "expanding that group If you go back and",
      "offset": 1859.679,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "look at how we built out AON the past 5",
      "offset": 1861.52,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "years in a similar fashion we planned",
      "offset": 1863.6,
      "duration": 4.319
    },
    {
      "lang": "en",
      "text": "ahead we invested ahead but we wanted to",
      "offset": 1865.76,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "see where opportunity existed So you're",
      "offset": 1867.919,
      "duration": 3.201
    },
    {
      "lang": "en",
      "text": "going to see over the this course of",
      "offset": 1869.76,
      "duration": 3.159
    },
    {
      "lang": "en",
      "text": "this calendar year expansion in that",
      "offset": 1871.12,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "alphaac salesforce We're looking now to",
      "offset": 1872.919,
      "duration": 4.201
    },
    {
      "lang": "en",
      "text": "expand We'll do that over the course of",
      "offset": 1875.44,
      "duration": 3.599
    },
    {
      "lang": "en",
      "text": "this year and we're set up well to grow",
      "offset": 1877.12,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "that product again with sequential",
      "offset": 1879.039,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "customers who've already adopted it and",
      "offset": 1880.96,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "getting new customers putting it through",
      "offset": 1882.96,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "the vac process and bringing it inhouse",
      "offset": 1884.24,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "So we're excited",
      "offset": 1886.72,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "Great Thanks Thanks Jim And then just on",
      "offset": 1889.2,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "Orion can you give us an update on how",
      "offset": 1891.52,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "things are progressing on the uh EU",
      "offset": 1893.36,
      "duration": 5.12
    },
    {
      "lang": "en",
      "text": "launch and you know any updated thoughts",
      "offset": 1895.84,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "on on the opportunity there you know I",
      "offset": 1898.48,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "guess you know a couple quarters into",
      "offset": 1900.72,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "the uh post to CD Mark",
      "offset": 1902.88,
      "duration": 5.84
    },
    {
      "lang": "en",
      "text": "Yeah it's a good um good question You",
      "offset": 1906.08,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "know it's funny We've done a really good",
      "offset": 1908.72,
      "duration": 2.72
    },
    {
      "lang": "en",
      "text": "job training people We have these",
      "offset": 1910.08,
      "duration": 3.439
    },
    {
      "lang": "en",
      "text": "scientific life symposiums that we've",
      "offset": 1911.44,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "held every six months for the last few",
      "offset": 1913.519,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "years And we just had one last weekend",
      "offset": 1915.36,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "in Barcelona well attended by global uh",
      "offset": 1916.96,
      "duration": 5.68
    },
    {
      "lang": "en",
      "text": "global folks came folks from the US came",
      "offset": 1920.72,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "over and spoke about Arian globally so",
      "offset": 1922.64,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "we're training and teaching physicians",
      "offset": 1925.12,
      "duration": 4.48
    },
    {
      "lang": "en",
      "text": "around the globe why Arian is so special",
      "offset": 1926.559,
      "duration": 5.201
    },
    {
      "lang": "en",
      "text": "and how it works so we've done a lot of",
      "offset": 1929.6,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "education we have a great distributor",
      "offset": 1931.76,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "network supporting us they also do",
      "offset": 1933.44,
      "duration": 3.839
    },
    {
      "lang": "en",
      "text": "training education for us in markets",
      "offset": 1935.279,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "that we don't have reach into so it help",
      "offset": 1937.279,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "expand that and we really expect now in",
      "offset": 1939.6,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "Q4 Steve you'll probably see some",
      "offset": 1941.279,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "revenue coming in in Q4 from Aron and",
      "offset": 1943.36,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "we'll start to build that we expect",
      "offset": 1945.6,
      "duration": 3.199
    },
    {
      "lang": "en",
      "text": "sequential growth going forward But",
      "offset": 1946.88,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "we've done a good job our team is really",
      "offset": 1948.799,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "strong globally They've done the right",
      "offset": 1950.48,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "education campaigns awareness campaigns",
      "offset": 1952.159,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "and now we're going to build that",
      "offset": 1954.48,
      "duration": 3.039
    },
    {
      "lang": "en",
      "text": "business out So you'll see a business",
      "offset": 1955.6,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "over time then with still strong US",
      "offset": 1957.519,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "growth in Aron and now the international",
      "offset": 1959.519,
      "duration": 4.801
    },
    {
      "lang": "en",
      "text": "growth kicking in And just a a reminder",
      "offset": 1961.44,
      "duration": 4.719
    },
    {
      "lang": "en",
      "text": "Steve that international market isn't as",
      "offset": 1964.32,
      "duration": 3.599
    },
    {
      "lang": "en",
      "text": "big as the US market And so you know",
      "offset": 1966.159,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "while we'll be a contributor um I",
      "offset": 1967.919,
      "duration": 4.081
    },
    {
      "lang": "en",
      "text": "wouldn't expect it to be a material",
      "offset": 1970.24,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "contributor right away Uh but as Jim",
      "offset": 1972,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "said we're very pleased with the",
      "offset": 1973.84,
      "duration": 2.079
    },
    {
      "lang": "en",
      "text": "traction that we're starting to get",
      "offset": 1974.88,
      "duration": 2.799
    },
    {
      "lang": "en",
      "text": "there",
      "offset": 1975.919,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "Got it Thanks Jim and Steve I'll jump",
      "offset": 1977.679,
      "duration": 6.36
    },
    {
      "lang": "en",
      "text": "back in queue Thanks Steve",
      "offset": 1979.279,
      "duration": 4.76
    },
    {
      "lang": "en",
      "text": "Thank you Our final question this",
      "offset": 1984.799,
      "duration": 3.681
    },
    {
      "lang": "en",
      "text": "morning comes from the line of Ye with",
      "offset": 1986.48,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "HC Wayright Please proceed with your",
      "offset": 1988.48,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "question",
      "offset": 1990.32,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "Good morning Uh this is Eduardo on for",
      "offset": 1992.72,
      "duration": 4.559
    },
    {
      "lang": "en",
      "text": "Yi Congrats on the great quarter Um in",
      "offset": 1995.12,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "the same line of Arian I'm curious how",
      "offset": 1997.279,
      "duration": 3.601
    },
    {
      "lang": "en",
      "text": "you view if you could give an update on",
      "offset": 1999.36,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "the timeline for the ambition study and",
      "offset": 2000.88,
      "duration": 4.32
    },
    {
      "lang": "en",
      "text": "how you see the results What do you",
      "offset": 2003.44,
      "duration": 4.959
    },
    {
      "lang": "en",
      "text": "measure as success there and how you see",
      "offset": 2005.2,
      "duration": 4.76
    },
    {
      "lang": "en",
      "text": "the application the below the knee",
      "offset": 2008.399,
      "duration": 3.921
    },
    {
      "lang": "en",
      "text": "indication uh do you see any specific",
      "offset": 2009.96,
      "duration": 3.88
    },
    {
      "lang": "en",
      "text": "advantages for the technology in that",
      "offset": 2012.32,
      "duration": 2.8
    },
    {
      "lang": "en",
      "text": "space that you could really leverage and",
      "offset": 2013.84,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "capture market there um just kind of",
      "offset": 2015.12,
      "duration": 3.439
    },
    {
      "lang": "en",
      "text": "your vision and rationale and the",
      "offset": 2017.36,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "ambition study and expectation",
      "offset": 2018.559,
      "duration": 4.401
    },
    {
      "lang": "en",
      "text": "Yeah thanks Eduardo It's a it's a great",
      "offset": 2021.039,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "question We're really excited about the",
      "offset": 2022.96,
      "duration": 5.36
    },
    {
      "lang": "en",
      "text": "ambition PTK study Um so we we mentioned",
      "offset": 2025.2,
      "duration": 6
    },
    {
      "lang": "en",
      "text": "that uh we're we're going through the um",
      "offset": 2028.32,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "the committees now We expect to begin",
      "offset": 2031.2,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "enrollment probably within the next",
      "offset": 2033.36,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "quarter or so Uh and then it's a pretty",
      "offset": 2034.96,
      "duration": 3.439
    },
    {
      "lang": "en",
      "text": "comprehensive trial So we'll give you",
      "offset": 2037.039,
      "duration": 2.64
    },
    {
      "lang": "en",
      "text": "some updates as we continue to go",
      "offset": 2038.399,
      "duration": 2.721
    },
    {
      "lang": "en",
      "text": "through it But I think your questions",
      "offset": 2039.679,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "around the rationale for the trial are",
      "offset": 2041.12,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "are are really important Uh so remember",
      "offset": 2043.279,
      "duration": 4.64
    },
    {
      "lang": "en",
      "text": "Arian already has a very broad",
      "offset": 2045.76,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "indication base So it's currently",
      "offset": 2047.919,
      "duration": 3.601
    },
    {
      "lang": "en",
      "text": "indicated for use in hard and soft",
      "offset": 2049.44,
      "duration": 4.239
    },
    {
      "lang": "en",
      "text": "calcifications above the knee below the",
      "offset": 2051.52,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "knee and in instant reinosis It's really",
      "offset": 2053.679,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "the only aerectomy product out there",
      "offset": 2056.32,
      "duration": 4.319
    },
    {
      "lang": "en",
      "text": "that has that versatile of a of a use",
      "offset": 2057.919,
      "duration": 4.96
    },
    {
      "lang": "en",
      "text": "case scenario The reason we're doing",
      "offset": 2060.639,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "this study is we we believe we've been",
      "offset": 2062.879,
      "duration": 6.24
    },
    {
      "lang": "en",
      "text": "able to to show before that using aron",
      "offset": 2065.679,
      "duration": 5.44
    },
    {
      "lang": "en",
      "text": "specifically below the knee in",
      "offset": 2069.119,
      "duration": 4.161
    },
    {
      "lang": "en",
      "text": "conjunction with balloon angoplasty will",
      "offset": 2071.119,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "provide better results than balloon",
      "offset": 2073.28,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "angoplasty by itself And we think that",
      "offset": 2074.56,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "that's a vitally important data point",
      "offset": 2076.72,
      "duration": 3.6
    },
    {
      "lang": "en",
      "text": "one to continue to support the use of",
      "offset": 2078.56,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "aron below the knee but potentially also",
      "offset": 2080.32,
      "duration": 3.88
    },
    {
      "lang": "en",
      "text": "to increase the overall market of",
      "offset": 2082.48,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "athererectomy Uh and so we're we're",
      "offset": 2084.2,
      "duration": 3.879
    },
    {
      "lang": "en",
      "text": "really excited about getting into this",
      "offset": 2086.48,
      "duration": 3.04
    },
    {
      "lang": "en",
      "text": "study We've we've worked with our",
      "offset": 2088.079,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "physician thought leaders Uh this is a",
      "offset": 2089.52,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "study that has a tremendous amount of",
      "offset": 2091.599,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "scientific rigor behind it and it's the",
      "offset": 2093.52,
      "duration": 3.839
    },
    {
      "lang": "en",
      "text": "kind of study that our customers are are",
      "offset": 2095.359,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "really looking forward to uh and and you",
      "offset": 2097.359,
      "duration": 4.961
    },
    {
      "lang": "en",
      "text": "know excited to work with us as we",
      "offset": 2100.32,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "continue to build out this type of data",
      "offset": 2102.32,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "set going forward So as we continue to",
      "offset": 2104.16,
      "duration": 2.8
    },
    {
      "lang": "en",
      "text": "move forward we'll give you some more",
      "offset": 2106,
      "duration": 2.48
    },
    {
      "lang": "en",
      "text": "details but we think it's exactly the",
      "offset": 2106.96,
      "duration": 3.119
    },
    {
      "lang": "en",
      "text": "right study to do with this type of",
      "offset": 2108.48,
      "duration": 4.599
    },
    {
      "lang": "en",
      "text": "technology",
      "offset": 2110.079,
      "duration": 3
    },
    {
      "lang": "en",
      "text": "That's great And and do you envision",
      "offset": 2113.839,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "obviously because it's already approved",
      "offset": 2116,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "in this indication you imagine that the",
      "offset": 2117.28,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "existing commercial team would be",
      "offset": 2119.44,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "sufficient to market it You're not",
      "offset": 2121.44,
      "duration": 4.08
    },
    {
      "lang": "en",
      "text": "expecting an expansion",
      "offset": 2122.88,
      "duration": 4.88
    },
    {
      "lang": "en",
      "text": "Yeah So if you look at how we built this",
      "offset": 2125.52,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "team we were certainly building ahead of",
      "offset": 2127.76,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "the curve as we were getting Arian from",
      "offset": 2129.28,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "from the initial launch to where it is",
      "offset": 2130.88,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "today As Jim has mentioned we're going",
      "offset": 2132.56,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "to continue to invest opportunistically",
      "offset": 2134.32,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "in our sales force I think you know",
      "offset": 2136.079,
      "duration": 2.881
    },
    {
      "lang": "en",
      "text": "don't expect you're going to see a",
      "offset": 2137.76,
      "duration": 2.56
    },
    {
      "lang": "en",
      "text": "significant amount of additional",
      "offset": 2138.96,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "investment right now in that business",
      "offset": 2140.32,
      "duration": 2.96
    },
    {
      "lang": "en",
      "text": "We're going to be making some",
      "offset": 2142.48,
      "duration": 2.639
    },
    {
      "lang": "en",
      "text": "investments in our throbectomy team as",
      "offset": 2143.28,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "Jim talked about as we head into next",
      "offset": 2145.119,
      "duration": 4.321
    },
    {
      "lang": "en",
      "text": "calendar year and getting that CPT code",
      "offset": 2147.52,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "with oncology Expect we'll be investing",
      "offset": 2149.44,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "in that business to support that We'll",
      "offset": 2151.04,
      "duration": 3.28
    },
    {
      "lang": "en",
      "text": "continue to invest in Arian There's no",
      "offset": 2152.8,
      "duration": 3.12
    },
    {
      "lang": "en",
      "text": "doubt about it But I wouldn't expect a",
      "offset": 2154.32,
      "duration": 5.2
    },
    {
      "lang": "en",
      "text": "huge bullish right away",
      "offset": 2155.92,
      "duration": 5.04
    },
    {
      "lang": "en",
      "text": "Okay that's really helpful Thank you so",
      "offset": 2159.52,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "much",
      "offset": 2160.96,
      "duration": 4.72
    },
    {
      "lang": "en",
      "text": "Thank you",
      "offset": 2163.92,
      "duration": 3.04
    },
    {
      "lang": "en",
      "text": "Thank you ladies and gentlemen That",
      "offset": 2165.68,
      "duration": 2.48
    },
    {
      "lang": "en",
      "text": "concludes our question and answer",
      "offset": 2166.96,
      "duration": 2.72
    },
    {
      "lang": "en",
      "text": "session I'll turn the floor back to Mr",
      "offset": 2168.16,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "Cleur for any final comments Thank you",
      "offset": 2169.68,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "very much I want to thank our team here",
      "offset": 2172.079,
      "duration": 2.961
    },
    {
      "lang": "en",
      "text": "at Andrew Dynamics They worked really",
      "offset": 2173.44,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "hard We've got a lot of priorities here",
      "offset": 2175.04,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "that we're getting over the goal line",
      "offset": 2176.88,
      "duration": 2.719
    },
    {
      "lang": "en",
      "text": "and getting things done and hopefully",
      "offset": 2178.4,
      "duration": 3.04
    },
    {
      "lang": "en",
      "text": "investors are seeing the progress we've",
      "offset": 2179.599,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "made in our transformation",
      "offset": 2181.44,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "Transformation that started with a",
      "offset": 2183.599,
      "duration": 3.441
    },
    {
      "lang": "en",
      "text": "portfolio shift So we've got really good",
      "offset": 2184.88,
      "duration": 4.4
    },
    {
      "lang": "en",
      "text": "teams now Our medical device products",
      "offset": 2187.04,
      "duration": 4.079
    },
    {
      "lang": "en",
      "text": "are sold to the markets that we can",
      "offset": 2189.28,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "become a major player in We do it with a",
      "offset": 2191.119,
      "duration": 3.761
    },
    {
      "lang": "en",
      "text": "great selling and marketing team a great",
      "offset": 2193.28,
      "duration": 3.44
    },
    {
      "lang": "en",
      "text": "clinical support team gives us",
      "offset": 2194.88,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "efficiency enables us to invest in our",
      "offset": 2196.72,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "medtech platforms that you heard about",
      "offset": 2198.88,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "today that have really large",
      "offset": 2200.48,
      "duration": 3.84
    },
    {
      "lang": "en",
      "text": "opportunities Our products are dynamic",
      "offset": 2202.24,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "and they're good Our design and",
      "offset": 2204.32,
      "duration": 3.519
    },
    {
      "lang": "en",
      "text": "development teams are great Our",
      "offset": 2205.92,
      "duration": 3.76
    },
    {
      "lang": "en",
      "text": "regulatory and market access teams are",
      "offset": 2207.839,
      "duration": 4
    },
    {
      "lang": "en",
      "text": "great And let's not forget too our",
      "offset": 2209.68,
      "duration": 3.679
    },
    {
      "lang": "en",
      "text": "supply chain teams while we're doing all",
      "offset": 2211.839,
      "duration": 2.881
    },
    {
      "lang": "en",
      "text": "this work in our market with our",
      "offset": 2213.359,
      "duration": 3.201
    },
    {
      "lang": "en",
      "text": "customers you know we announced over a",
      "offset": 2214.72,
      "duration": 3.68
    },
    {
      "lang": "en",
      "text": "year ago we're changing our supply team",
      "offset": 2216.56,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "base how we're operating where we're",
      "offset": 2218.4,
      "duration": 2.959
    },
    {
      "lang": "en",
      "text": "going to operate They've done a really",
      "offset": 2219.92,
      "duration": 2.72
    },
    {
      "lang": "en",
      "text": "good job delivering on that",
      "offset": 2221.359,
      "duration": 3.041
    },
    {
      "lang": "en",
      "text": "transformation over time And that's",
      "offset": 2222.64,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "going to make sure we have a stable",
      "offset": 2224.4,
      "duration": 3.52
    },
    {
      "lang": "en",
      "text": "supply chain to supply our customers for",
      "offset": 2226,
      "duration": 3.92
    },
    {
      "lang": "en",
      "text": "years to come and also take some of that",
      "offset": 2227.92,
      "duration": 3.919
    },
    {
      "lang": "en",
      "text": "stranded cost out that will drop to the",
      "offset": 2229.92,
      "duration": 3.36
    },
    {
      "lang": "en",
      "text": "bottom line over the next two fiscal",
      "offset": 2231.839,
      "duration": 3.681
    },
    {
      "lang": "en",
      "text": "years So our company's well uh well set",
      "offset": 2233.28,
      "duration": 4.16
    },
    {
      "lang": "en",
      "text": "up to succeed for years to come Thank",
      "offset": 2235.52,
      "duration": 4.8
    },
    {
      "lang": "en",
      "text": "you for joining us today",
      "offset": 2237.44,
      "duration": 4.24
    },
    {
      "lang": "en",
      "text": "Thank you This concludes today's",
      "offset": 2240.32,
      "duration": 2.799
    },
    {
      "lang": "en",
      "text": "conference You may disconnect your lines",
      "offset": 2241.68,
      "duration": 2.88
    },
    {
      "lang": "en",
      "text": "at this time Thank you for your",
      "offset": 2243.119,
      "duration": 3.841
    },
    {
      "lang": "en",
      "text": "participation",
      "offset": 2244.56,
      "duration": 2.4
    }
  ],
  "cleanText": null,
  "dumpedAt": "2025-07-21T18:43:24.508Z"
}